SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '19Y'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AJ6_A_NOVA1_1 (GYRASE) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 7 / 9 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96THR A 169 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 (-3.7A) | 0.56A | 1aj6A-4hz5A:27.9 | 1aj6A-4hz5A:53.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DBB_H_STRH229_1 (IGG1-KAPPA DB3 FAB(HEAVY CHAIN)IGG1-KAPPA DB3 FAB(LIGHT CHAIN)) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 5 / 8 | GLY A 151ASN A 126GLY A 150TRP A 131VAL A 171 | NoneNoneNoneNone19Y A 301 ( 4.6A) | 1.44A | 1dbbH-4hz5A:undetectable1dbbL-4hz5A:undetectable | 1dbbH-4hz5A:21.251dbbL-4hz5A:23.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 8 / 12 | ASP A 52GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138THR A 169 | None19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.76A | 1kijA-4hz5A:27.7 | 1kijA-4hz5A:40.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 9 / 12 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ALA A 122ARG A 138THR A 169 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.1A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.58A | 1kijB-4hz5A:28.2 | 1kijB-4hz5A:40.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_A_NOVA1300_1 (TOPOISOMERASE IVSUBUNIT B) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 10 / 12 | ASN A 49ASP A 52GLU A 53ASP A 76ARG A 79MET A 81PRO A 82ILE A 96ARG A 138THR A 169 | 19Y A 301 (-3.8A)None19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-3.7A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.70A | 1s14A-4hz5A:25.3 | 1s14A-4hz5A:39.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_B_NOVB2300_1 (TOPOISOMERASE IVSUBUNIT B) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 9 / 12 | ASN A 49ASP A 52GLU A 53ASP A 76ARG A 79MET A 81PRO A 82ILE A 96ARG A 138 | 19Y A 301 (-3.8A)None19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-3.7A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A) | 0.76A | 1s14B-4hz5A:27.3 | 1s14B-4hz5A:39.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LPS_A_NOVA901_1 (TOPOISOMERASE IVSUBUNIT B) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 10 / 12 | ASN A 49ASP A 52GLU A 53ASP A 76ARG A 79MET A 81PRO A 82ILE A 96ARG A 138THR A 169 | 19Y A 301 (-3.8A)None19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-3.7A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.71A | 3lpsA-4hz5A:27.9 | 3lpsA-4hz5A:29.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 7 / 11 | ASN A 49ASP A 52ASP A 76MET A 81PRO A 82ARG A 138THR A 169 | 19Y A 301 (-3.8A)None19Y A 301 (-3.3A)19Y A 301 (-3.7A)19Y A 301 (-4.0A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.63A | 4urnA-4hz5A:30.9 | 4urnA-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 7 / 11 | ASN A 49ASP A 52ASP A 76PRO A 82ILE A 96ARG A 138THR A 169 | 19Y A 301 (-3.8A)None19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.72A | 4urnA-4hz5A:30.9 | 4urnA-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 8 / 11 | ASN A 49GLU A 53ASP A 76ARG A 79MET A 81PRO A 82ARG A 138THR A 169 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-3.7A)19Y A 301 (-4.0A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.59A | 4urnA-4hz5A:30.9 | 4urnA-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 8 / 11 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138THR A 169 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.64A | 4urnA-4hz5A:30.9 | 4urnA-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 7 / 11 | ASN A 49ASP A 52ASP A 76MET A 81PRO A 82ARG A 138THR A 169 | 19Y A 301 (-3.8A)None19Y A 301 (-3.3A)19Y A 301 (-3.7A)19Y A 301 (-4.0A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.71A | 4urnB-4hz5A:28.2 | 4urnB-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 7 / 11 | ASN A 49ASP A 52ASP A 76PRO A 82ILE A 96ARG A 138THR A 169 | 19Y A 301 (-3.8A)None19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.78A | 4urnB-4hz5A:28.2 | 4urnB-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 8 / 11 | ASN A 49GLU A 53ASP A 76ARG A 79MET A 81PRO A 82ARG A 138THR A 169 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-3.7A)19Y A 301 (-4.0A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.52A | 4urnB-4hz5A:28.2 | 4urnB-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 8 / 11 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138THR A 169 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.58A | 4urnB-4hz5A:28.2 | 4urnB-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 7 / 11 | ASN A 49ASP A 52ASP A 76MET A 81PRO A 82ARG A 138THR A 169 | 19Y A 301 (-3.8A)None19Y A 301 (-3.3A)19Y A 301 (-3.7A)19Y A 301 (-4.0A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.70A | 4urnC-4hz5A:31.2 | 4urnC-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 7 / 11 | ASN A 49ASP A 52ASP A 76PRO A 82ILE A 96ARG A 138THR A 169 | 19Y A 301 (-3.8A)None19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.74A | 4urnC-4hz5A:31.2 | 4urnC-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 8 / 11 | ASN A 49GLU A 53ASP A 76ARG A 79MET A 81PRO A 82ARG A 138THR A 169 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-3.7A)19Y A 301 (-4.0A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.53A | 4urnC-4hz5A:31.2 | 4urnC-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 8 / 11 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138THR A 169 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.55A | 4urnC-4hz5A:31.2 | 4urnC-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 7 / 12 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A) | 0.52A | 4uroA-4hz5A:30.2 | 4uroA-4hz5A:54.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 7 / 12 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A) | 0.54A | 4uroB-4hz5A:30.1 | 4uroB-4hz5A:54.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 7 / 12 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A) | 0.48A | 4uroC-4hz5A:30.3 | 4uroC-4hz5A:54.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B) |
4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) | 8 / 12 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138THR A 169 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.54A | 4uroD-4hz5A:29.9 | 4uroD-4hz5A:54.08 |